| Company Name: |
Hubei Ipodix Biotechnology Co.,Ltd.
|
| Tel: |
18007124176 19384116026 |
| Email: |
2706668885@qq.com |
| Products Intro: |
Product Name:KSR1 antibody
Purity:99% Package:50ul/RMB 1280;100ul/RMB 2180
|
| Company Name: |
GeneTex, Inc.
|
| Tel: |
0755-26755892 1-949-553-1900 |
| Email: |
international@genetex.com |
| Products Intro: |
Product Name:KSR1 antibody
|
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Email: |
Enzoname@qq.com |
| Products Intro: |
Product Name:KSR1 Antibody
|
| Company Name: |
Abmart Inc
|
| Tel: |
4006-123-828 13162017139 |
| Email: |
market@ab-mart.com |
| Products Intro: |
Product Name:KSR1 Antibody
|
|
| | KSR1 antibody Chemical Properties |
| | KSR1 antibody Usage And Synthesis |
| Source | Rabbit | | Reactivity | Human;Mouse;Rat;Monkey | | Background | KSR1 was identified from a genetic screen in Drosophila and C. elegans as a component of the Ras signaling pathway. KSR1 has a putative carboxy-terminal kinase domain that lacks a key Lys residue for phospho-group transfer. Although reports indicate that ceramide and EGF activate KSR1, other evidence demonstrates that KSR1 regulates Raf in a kinase-independent manner. It is now widely accepted that KSR1 functions as a scaffold that binds MEK1/2 and 14-3-3 protein constitutively and binds ERK1/2 in a Ras activation-dependent manner. HSP70/HSP90 and p50 Cdc37 associate with the KSR1 complex to ensure its stability. Multiple phosphorylation sites have been identified: Ser297 and Ser392 mediate 14-3-3 binding, and putative MAPK phosphorylation sites include Thr260, Thr274 and Ser443. C-TAK1 binds and phosphorylates KSR1 at Ser392 in quiescent cells. In response to stimuli, Ser392 is dephosphorylated by PP2A, which leads to ERK1/2 association and allows the KSR1 complex to translocate from cytosol to membrane, where the MAPK pathway is activated. IMP, a Ras-responsive E3 ubiquitin ligase, is also involved in interaction with KSR1 and may regulate its localization and stability. Very high expression levels of KSR1 inhibit MAPK signaling, whereas physiological levels promote MAPK signaling, indicating that the scaffold protein can turn signaling "on" or "off" depending on the scaffold concentration. | | References | [1] Morrison, D.K. (2001) J. Cell Sci. 114, 1609-1612.
[2] Zhang, Y. et al. (1997) Cell 89, 63-72.
[3] Xing, H.R. and Kolesnick, R. (2001) J. Biol. Chem. 276, 9733-9741.
[4] Michaud, N. R. et al. (1997) Proc. Natl. Acad. Sci. USA 94, 12792-12796.
[5] Stewart, S. et al. (1999) Mol. Cell. Biol. 19, 5523-5534.
[6] Muller, J. et al. (2001) Mol. Cell 8, 983-993.
[7] Cacace, A. M. et al. (1999) Mol. Cell. Biol. 19, 229-240.
[8] Ory, S. et al. (2003) Curr. Biol. 13, 1356-1364.
[9] Matheny, S. A. et al. (2004) Nature 427, 256-260.
[10] Kortum, R.L. and Lewis, R.E. (2004) Mol Cell Biol 24, 4407-16. |
| | KSR1 antibody Preparation Products And Raw materials |
|